EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia

Caroline Klindt, Andre Fuchs, Kristina Behnke, Carola Dröge, Kirsten Alexandra Eberhardt, Hans Christian Orth, Frieder Pfäfflin, Andreas Schönfeld, Tamara Nordmann, Million Getachew Mesfun, Verena Keitel, Tom Luedde und 3 weitere

Infection · 2025

DOI: 10.1007/s15010-025-02632-7 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Infection, 2025. Verfasst von Caroline Klindt und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düssel…. Hauptthemen laut MEDLINE: Antitubercular Agents, Chemical and Drug Induced Liver Injury, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Augsburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Drug-induced liver injury (DILI) is a relevant adverse event of tuberculosis treatment (TBT) especially in sub-Saharan Africa, but data remains limited. Genetic hepatic transport proteins polymorphisms (HTPP) are potential contributors. This study aimed to assess frequency and timing of DILI, identify risk factors, and explore the association of HTPP with DILI risk in Ethiopian TBT-patients.

Methods

In this prospective study, 424 confirmed tuberculosis patients in Ethiopian were recruited before initiation of TBT. Liver function tests were conducted during the first 8 weeks of treatment. Baseline evaluations included sociodemographic-, lifestyle- and clinical data including testing for viral co-infections, and HTPP as well as liver stiffness measurement by transient elastography (TE). Multivariable logistic regression, Cox proportional hazards models, and Fine and Gray competing risks analyses were employed for statistical analysis.

Results

Cumulative DILI incidence was 16.0% with 4.2% classified as severe occurring most commonly within the first two weeks. Urban residence (OR 2.00, 95% CI 1.03–3.84; HR 1.80, 95% CI 1.00–3.22) was associated with increased DILI risk. In the competing risks model, urban residence (sHR 6.26, p = 0.010) and pathologic TE (sHR 5.23, p = 0.005) predicted severe DILI. The investigated HTPPs were not significantly associated with DILI.

Conclusion

DILI is a common early complication of TBT in Ethiopian patients. Assessment of sociodemographic factors and TE before TBT may help identify high-risk individuals and offers a pragmatic approach for DILI management in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsChemical and Drug Induced Liver InjuryTuberculosisHumansEthiopiaMaleFemaleProspective StudiesAdultRisk FactorsMiddle AgedYoung AdultIncidenceAdolescent

Stichwörter der Autor:innen

DILIHepatobiliary transportHepatotoxicitySingle nucleotide polymorphismTBTransient elastography

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Department of Medicine II, Medical Faculty, Mannheim of Heidelberg University, Mannheim, Germany.
  • Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. andre.fuchs@uk-augsburg.de.
  • Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. andre.fuchs@uk-augsburg.de.
  • Hirsch Institute for Tropical Medicine, Asella, Ethiopia. andre.fuchs@uk-augsburg.de.
  • Clinic for Gastroenterology, Hepatology and Infectious Diseases, Otto-von Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.

Förderung

  • Universitätsklinikum Augsburg

Zitieren

APA

Klindt, C., Fuchs, A., Behnke, K., Dröge, C., Eberhardt, K. A., Orth, H. C., Pfäfflin, F., Schönfeld, A., Nordmann, T., Mesfun, M. G., Keitel, V., Luedde, T., Tufa, T. B., Jensen, B. O., & Feldt, T. (2025). Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia. Infection. https://doi.org/10.1007/s15010-025-02632-7

Vancouver

Klindt C, Fuchs A, Behnke K, Dröge C, Eberhardt KA, Orth HC, et al. Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia. Infection. 2025. doi:10.1007/s15010-025-02632-7

BibTeX
@article{Klindt2025,
  author = {Klindt, Caroline and Fuchs, Andre and Behnke, Kristina and Dröge, Carola and Eberhardt, Kirsten Alexandra and Orth, Hans Christian and Pfäfflin, Frieder and Schönfeld, Andreas and Nordmann, Tamara and Mesfun, Million Getachew and Keitel, Verena and Luedde, Tom and Tufa, Tafese Beyene and Jensen, Björn-Erik Ole and Feldt, Torsten},
  title = {Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-025-02632-7}
}
Kostenlos starten →